This document discusses bronchitis in children, including defining bronchitis, causes, pathogenesis, clinical presentation, diagnosis, and treatment approaches. It describes bronchitis as an inflammatory disease of the bronchi mucous membrane causing cough and sputum production. The document outlines infectious and non-infectious causes and provides details on viral, bacterial, and mixed etiologies. It recommends treatment approaches including antiviral medications, antibiotics, and medications to reduce inflammation and normalize mucus secretion and cough.
Bronchiectasis is a permanent abnormal dilatation of the bronchi caused by recurrent infection or inflammation. It can be caused by lung infections like pneumonia or tuberculosis, cystic fibrosis, bronchial compression by tumors or lymph nodes, impaired mucociliary clearance in conditions like Kartagener's syndrome, or immunodeficiencies. Symptoms include recurrent or chronic cough, sputum production, hemoptysis, fever, and dyspnea. Diagnosis is made through high resolution CT of the chest. Treatment involves antibiotics for acute exacerbations, inhaled antibiotics to prevent Pseudomonas colonization, airway clearance techniques, and surgery or embolization for severe cases.
Lung abscesses are collections of pus within the lung tissue that can develop from infections like pneumonia or from aspirating foreign materials. Symptoms may include cough, fever, chest pain, and shortness of breath. Diagnosis involves chest x-rays, CT scans, and sputum cultures. Treatment consists of antibiotics chosen based on culture results, drainage procedures, and occasionally surgery for complications. Nursing care focuses on airway clearance techniques, nutrition, pain management, and educating patients on long-term antibiotic use and preventing recurrence.
This document provides information on pneumonia, lung abscess, and bronchiectasis. It discusses the clinical classification, pathophysiology, etiology, risk factors, clinical manifestations, diagnosis, and management of pneumonia. It also covers the etiology, symptoms and diagnosis, and management of lung abscess. Finally, it discusses the introduction, etiology, clinical manifestations and diagnosis, and management of bronchiectasis.
Lung abscess is a localized necrotic lesion in the lung tissue containing pus that forms a cavity. It is generally caused by aspiration of anaerobic bacteria from the GI tract into the lungs. The most common areas affected are the superior segment of the lower lobes and the posterior segment of the upper lobes. Clinical manifestations include cough producing foul-smelling pus, fever, chest pain, and shortness of breath.
Lung abscess is a localized infection and necrosis of lung tissue that forms a cavity containing pus. It is usually caused by aspiration or infection traveling via the bloodstream. Common symptoms include fever, cough, sputum production, and weight loss. Diagnosis involves chest x-ray or CT scan to identify lung cavities. Treatment consists of antibiotics chosen based on suspected bacteria and may require hospitalization. Complications can include spread of infection to the pleural space or amyloidosis.
Lung abscess is caused by microbial infection that leads to necrosis of lung tissue, forming a cavity. Symptoms include cough, expectoration of purulent sputum, and abnormalities on imaging. Lung abscesses are usually polymicrobial infections from oral anaerobes following aspiration. Risk factors include predisposition to aspiration, poor dental health, and conditions compromising immunity. Diagnosis involves chest imaging showing cavitary lesions and microbiological testing of sputum or lung aspirates. Treatment involves antibiotics and drainage of complications like empyema.
Lung abscess is a type of liquefactive necrosis and formation of cavities greater than 2cm in the lung tissue caused by microbial infection. It is often caused by aspiration during anesthesia, sedation, or unconsciousness. Risk factors include age, male sex, and conditions like periodontal disease or dysphagia. Symptoms include cough with foul sputum, chest pain, fever, and weight loss. Diagnosis involves imaging like x-ray or CT scan showing spherical areas of density and air-fluid levels. Treatment is generally broad spectrum antibiotics for 6-8 weeks along with drainage procedures in some cases.
This document discusses bronchiectasis, including its definition, etiology, clinical features, diagnosis, management, and complications. Some key points:
- Bronchiectasis is irreversible dilation of the airways caused by infection or other insults that damages the airways and impairs mucus clearance.
- It has various etiologies including infection, immunodeficiency, genetic disorders, and aspiration. Recurrent infections lead to a vicious cycle of inflammation and further airway damage.
- Symptoms include chronic productive cough and sputum. Investigations include chest CT, which shows characteristic findings like airway dilation.
- Management focuses on airway clearance, antibiotics for infections, and
Bronchiectasis is a permanent abnormal dilatation of the bronchi caused by recurrent infection or inflammation. It can be caused by lung infections like pneumonia or tuberculosis, cystic fibrosis, bronchial compression by tumors or lymph nodes, impaired mucociliary clearance in conditions like Kartagener's syndrome, or immunodeficiencies. Symptoms include recurrent or chronic cough, sputum production, hemoptysis, fever, and dyspnea. Diagnosis is made through high resolution CT of the chest. Treatment involves antibiotics for acute exacerbations, inhaled antibiotics to prevent Pseudomonas colonization, airway clearance techniques, and surgery or embolization for severe cases.
Lung abscesses are collections of pus within the lung tissue that can develop from infections like pneumonia or from aspirating foreign materials. Symptoms may include cough, fever, chest pain, and shortness of breath. Diagnosis involves chest x-rays, CT scans, and sputum cultures. Treatment consists of antibiotics chosen based on culture results, drainage procedures, and occasionally surgery for complications. Nursing care focuses on airway clearance techniques, nutrition, pain management, and educating patients on long-term antibiotic use and preventing recurrence.
This document provides information on pneumonia, lung abscess, and bronchiectasis. It discusses the clinical classification, pathophysiology, etiology, risk factors, clinical manifestations, diagnosis, and management of pneumonia. It also covers the etiology, symptoms and diagnosis, and management of lung abscess. Finally, it discusses the introduction, etiology, clinical manifestations and diagnosis, and management of bronchiectasis.
Lung abscess is a localized necrotic lesion in the lung tissue containing pus that forms a cavity. It is generally caused by aspiration of anaerobic bacteria from the GI tract into the lungs. The most common areas affected are the superior segment of the lower lobes and the posterior segment of the upper lobes. Clinical manifestations include cough producing foul-smelling pus, fever, chest pain, and shortness of breath.
Lung abscess is a localized infection and necrosis of lung tissue that forms a cavity containing pus. It is usually caused by aspiration or infection traveling via the bloodstream. Common symptoms include fever, cough, sputum production, and weight loss. Diagnosis involves chest x-ray or CT scan to identify lung cavities. Treatment consists of antibiotics chosen based on suspected bacteria and may require hospitalization. Complications can include spread of infection to the pleural space or amyloidosis.
Lung abscess is caused by microbial infection that leads to necrosis of lung tissue, forming a cavity. Symptoms include cough, expectoration of purulent sputum, and abnormalities on imaging. Lung abscesses are usually polymicrobial infections from oral anaerobes following aspiration. Risk factors include predisposition to aspiration, poor dental health, and conditions compromising immunity. Diagnosis involves chest imaging showing cavitary lesions and microbiological testing of sputum or lung aspirates. Treatment involves antibiotics and drainage of complications like empyema.
Lung abscess is a type of liquefactive necrosis and formation of cavities greater than 2cm in the lung tissue caused by microbial infection. It is often caused by aspiration during anesthesia, sedation, or unconsciousness. Risk factors include age, male sex, and conditions like periodontal disease or dysphagia. Symptoms include cough with foul sputum, chest pain, fever, and weight loss. Diagnosis involves imaging like x-ray or CT scan showing spherical areas of density and air-fluid levels. Treatment is generally broad spectrum antibiotics for 6-8 weeks along with drainage procedures in some cases.
This document discusses bronchiectasis, including its definition, etiology, clinical features, diagnosis, management, and complications. Some key points:
- Bronchiectasis is irreversible dilation of the airways caused by infection or other insults that damages the airways and impairs mucus clearance.
- It has various etiologies including infection, immunodeficiency, genetic disorders, and aspiration. Recurrent infections lead to a vicious cycle of inflammation and further airway damage.
- Symptoms include chronic productive cough and sputum. Investigations include chest CT, which shows characteristic findings like airway dilation.
- Management focuses on airway clearance, antibiotics for infections, and
PATHOGENESIS OF BRONCHIECTASIS BY DR BASHIR AHMED DAR ASSOCIATE PROFESSOR MED...Prof Dr Bashir Ahmed Dar
Dr Bashir Ahmed Dar associate professor medicine chinkipora sopore kashmir presently working in malaysia speaks about bronchiectasis.Bronchiectasis which is defined as the irreversible dilatation of the cartilage-containing airways bronchi or bronchioles.
The document discusses lung abscess, including its definition, classification, microbiology, risk factors, pathophysiology, clinical features, diagnosis and treatment. A lung abscess is a microbial infection that causes necrosis of lung tissue, forming a cavity. It is usually caused by aspiration of oral anaerobic bacteria. Symptoms include cough, sputum production and fever. Diagnosis involves imaging showing a cavity with an air-fluid level. Treatment involves long-term antibiotics targeting the causative bacteria. Surgery is rarely needed except for failure of medical management or an underlying condition.
Lung abscesses represent necrosis and cavitation of the lung due to microbial infection. They are typically marked by a single cavity greater than 2cm in diameter. Primary lung abscesses usually arise from aspiration of oral bacteria and affect the lower lobes. Secondary abscesses occur in the context of an underlying condition like obstruction or immunosuppression. Treatment involves antibiotics targeting anaerobic bacteria for several weeks and sometimes drainage for large abscesses. Complications include persistent cysts, recurrence, and life-threatening bleeding or aspiration.
Bronchiectasis is an abnormal, permanent dilatation of the bronchi. It was first discovered in 1819 by René Laennec, the inventor of the stethoscope. Common causes include cystic fibrosis, childhood infections like pertussis and measles, and obstructive lung diseases. Patients present with chronic cough, sputum production, and recurrent lung infections. Diagnosis is made through chest imaging like CT scan which can classify the type of bronchiectasis. Treatment involves airway clearance techniques, antibiotics, anti-inflammatory drugs, and surgery in some severe cases. The goal is to treat infections, clear secretions, and reduce inflammation.
Lung abscesses can be classified based on duration, etiology, pathogen, and location. Acute abscesses present within 2 weeks and are usually caused by virulent bacteria like S. aureus, while chronic abscesses last over 4-6 weeks and may be caused by tumors or less virulent anaerobes. Lung abscesses are most commonly caused by aspiration of infected materials or inadequately treated pneumonia. Common pathogens include anaerobic bacteria like Prevotella species and aerobic bacteria like S. aureus. Symptoms vary from indolent over weeks to acute, with subacute onset associated with aspiration.
Bronchiectasis
A condition characterized by chronic permanent dilation & destruction of bronchi due to destructive changes in the elastic and muscular layers of bronchial walls.
The common thread in the pathogenesis of bronchiectasis consists of difficulty clearing secretions & recurrent infections with a “vicious circle” of infection and inflammation resulting in airway injury and remodelling.
PLEASE REFER TO REFERENCE TEXTBOOKS FOR CLARITY.
BRONCHIECTASIS BY DR BASHIR AHMED DAR ASSOCIATE PROFESSOR MEDICINE SOPORE KAS...Prof Dr Bashir Ahmed Dar
Bronchiectasis is the irreversible widening of the airways. It develops through one of three mechanisms: damage to the bronchial wall from infections or inflammation, obstruction of the bronchial lumen, or traction from fibrosis in adjacent tissues. Repeated infections, mucus plugging, and bacterial overgrowth lead to a vicious cycle of progressive airway damage and widening in bronchiectasis. Various congenital defects or conditions like cystic fibrosis can also predispose individuals to developing bronchiectasis by impairing mucus clearance from the lungs.
Bronchiectasis is a chronic lung condition characterized by abnormal dilation of the bronchi and bronchioles. It can be caused by airway obstruction, infections, genetic disorders like cystic fibrosis, or immunodeficiencies. Symptoms include chronic cough, excessive sputum production, recurring lung infections, shortness of breath, and finger clubbing. Diagnosis involves chest imaging, sputum analysis, and pulmonary function tests. Treatment focuses on airway clearance techniques, antibiotics for infections, and sometimes surgery to remove diseased portions of the lung.
Empyema is the accumulation of pus in the pleural space caused by a lung infection spreading. It is classified into three stages based on the fluid characteristics. Common causes are bacterial pneumonias like Streptococcus pneumoniae. Symptoms include fever, cough, and chest pain. Chest x-ray or ultrasound can detect fluid buildup. Treatment involves antibiotics, drainage of pus, and occasionally surgery. The goal is to clear the infection, expand the lung, and resolve symptoms. Complications may include persistent fever, abscesses, or fistulae if not properly treated.
Cavitary lung lesions can have various causes including cancer, infection, autoimmune disease, vascular embolism, and trauma. On imaging, characteristics like wall thickness, inner contour, location, and other associated findings provide clues to the underlying etiology. Malignant processes tend to have thicker walls over 15mm while benign lesions usually have thinner walls under 4mm. Infectious cavities often have irregular inner walls and may contain fluid levels. Autoimmune diseases typically cause multiple bilateral nodules. The clinical context is also important for determining the most likely diagnosis.
This document discusses empyema, which is an accumulation of thick, purulent fluid in the pleural space caused by bacterial pneumonia, lung abscess, chest trauma, or surgery. Common organisms include Staphylococcus aureus and Streptococcus pneumoniae. Empyema develops from a parapneumonic effusion through exudative, fibrino-purulent, and organizing stages. Symptoms include fever, chest pain, and dyspnea. Diagnosis involves imaging and culture of pleural fluid. Treatment requires drainage of fluid, antibiotics for 10-14 days intravenously or longer orally, and oxygen. Nursing diagnoses relate to impaired gas exchange, acute pain, and risk for activity intolerance.
Bronchiectasis is the irreversible dilatation of the airways. It can be cylindrical, varicose, or cystic in appearance. Common causes include post-infection, infection by bacteria or mycobacteria, airway obstruction, and immunodeficiencies. Symptoms include persistent cough with sputum, hemoptysis, dyspnea, and wheezing. Diagnosis involves chest x-ray, CT scan, sputum culture, and lung function tests. Treatment goals are to eliminate the cause, improve airway clearance, control infection, and reverse airflow obstruction using antibiotics, chest physiotherapy, bronchodilators, and surgery in some cases.
Lung abscess is a localized, suppurative infection within the lung that forms a cavitating area. It can be caused by inadequately treated pneumonia, aspiration of substances like alcohol or gastric contents, bronchial obstruction by tumors or foreign bodies, pulmonary infarction, septic emboli from infections elsewhere in the body, or subphrenic or hepatic abscesses. Symptoms include swinging fever, cough, purulent sputum, chest pain, hemoptysis, malaise, weight loss, finger clubbing, anemia, and crepitations. Diagnosis involves blood tests, sputum analysis, chest x-rays, and CT scans. Treatment consists of antibiotics selected based on culture sensitivities
Bronchiectasis is a chronic lung condition defined by abnormal dilation of the bronchi. It is commonly caused by previous lung infections but can also be due to other issues like airway obstruction, immune deficiencies, or genetic disorders. Patients present with excessive sputum production, chronic cough, recurrent lung infections, and sometimes blood in the sputum or cough. Diagnosis involves imaging tests like CT scans that show dilated bronchi. Treatment focuses on airway clearance and antibiotics to prevent infections. Surgery may be considered for severe cases or massive bleeding in the lungs.
Lung abscess is a necrotic pulmonary infection that forms cavities containing fluid or debris. It is usually caused by microbial infection following aspiration or pneumonia. Without treatment, lung abscess was often fatal, but antibiotics have greatly improved outcomes. Most lung abscesses are now cured with prolonged antibiotic therapy targeting the usual culprits of anaerobic bacteria and occasionally aerobic pathogens. Imaging helps confirm the diagnosis and monitor response to medical management, with surgery rarely needed for uncomplicated cases.
Common suppurative diseases of lung- Bronchiectasis...!Sharmin Susiwala
Bronchiectasis is a condition characterized by irreversible dilation of part of the bronchial tree due to damage to elastic and muscular components, usually from acute or chronic infection. It requires both an infectious insult and impaired drainage or airway obstruction. Symptoms include daily cough and sputum production. Diagnosis involves chest imaging showing abnormal lung signs and high-resolution CT scanning. Treatment focuses on controlling infections with antibiotics and clearing secretions. Complications can include lung damage and recurrent pneumonia.
This document contains 12 multiple choice questions about lung abscesses. The questions cover topics such as the characteristics of different stages of lung abscess, common symptoms of pneumonia, sites commonly affected by lung abscess, typical blood test results for lung abscess patients, and the preferred treatment for lung abscesses. Radiological features of lung consolidation are also discussed.
Lung abscess or pulmonary abscess is a local suppurative process within the lung.
It is characterized by accumulation of pus accompanied by the destruction of lung tissue.
Content:
Definition
Etiology and pathogenesis
Morphology
Clinical Features
Diagnostic findings
Prevention
Management
1. Lung abscess is a localized necrotic lesion in the lung tissue containing pus, generally caused by aspiration of anaerobic bacteria. It starts as pneumonia, with areas of lung tissue dying off and forming cavities containing pus.
2. Symptoms include fever, cough, sputum production, and chest pain. Diagnosis involves chest x-rays and CT scans to identify fluid-filled cavities.
3. Treatment depends on the size and includes antibiotics, drainage of large abscesses through the chest wall, and surgery if complications occur.
The document provides an overview of respiratory disorders and diseases. It discusses diagnostic tests for respiratory conditions like spirometry and blood gas tests. Common respiratory diseases covered include upper respiratory infections like the common cold, sinusitis, pneumonia, lung cancer, asthma, and chronic obstructive pulmonary disease (COPD). Specific conditions like emphysema and chronic bronchitis are also examined, outlining their pathophysiology, signs and symptoms, diagnosis, and treatment.
Respiratory dis. presentation1 for gen path copy (2)Art Arts
1) Respiratory diseases are mainly caused by inhalation of infectious agents, allergens, irritants, and carcinogens. The lungs are open to the environment and lack regenerative abilities.
2) Chronic obstructive pulmonary diseases (COPD) include chronic bronchitis, emphysema, bronchiectasis, and asthma. Tobacco smoke is a major cause and leads to airway obstruction.
3) Pneumonia can result from impaired pulmonary defenses and host resistance. Bacterial and viral pathogens are common causes and treatment involves antibiotics and supportive care.
PATHOGENESIS OF BRONCHIECTASIS BY DR BASHIR AHMED DAR ASSOCIATE PROFESSOR MED...Prof Dr Bashir Ahmed Dar
Dr Bashir Ahmed Dar associate professor medicine chinkipora sopore kashmir presently working in malaysia speaks about bronchiectasis.Bronchiectasis which is defined as the irreversible dilatation of the cartilage-containing airways bronchi or bronchioles.
The document discusses lung abscess, including its definition, classification, microbiology, risk factors, pathophysiology, clinical features, diagnosis and treatment. A lung abscess is a microbial infection that causes necrosis of lung tissue, forming a cavity. It is usually caused by aspiration of oral anaerobic bacteria. Symptoms include cough, sputum production and fever. Diagnosis involves imaging showing a cavity with an air-fluid level. Treatment involves long-term antibiotics targeting the causative bacteria. Surgery is rarely needed except for failure of medical management or an underlying condition.
Lung abscesses represent necrosis and cavitation of the lung due to microbial infection. They are typically marked by a single cavity greater than 2cm in diameter. Primary lung abscesses usually arise from aspiration of oral bacteria and affect the lower lobes. Secondary abscesses occur in the context of an underlying condition like obstruction or immunosuppression. Treatment involves antibiotics targeting anaerobic bacteria for several weeks and sometimes drainage for large abscesses. Complications include persistent cysts, recurrence, and life-threatening bleeding or aspiration.
Bronchiectasis is an abnormal, permanent dilatation of the bronchi. It was first discovered in 1819 by René Laennec, the inventor of the stethoscope. Common causes include cystic fibrosis, childhood infections like pertussis and measles, and obstructive lung diseases. Patients present with chronic cough, sputum production, and recurrent lung infections. Diagnosis is made through chest imaging like CT scan which can classify the type of bronchiectasis. Treatment involves airway clearance techniques, antibiotics, anti-inflammatory drugs, and surgery in some severe cases. The goal is to treat infections, clear secretions, and reduce inflammation.
Lung abscesses can be classified based on duration, etiology, pathogen, and location. Acute abscesses present within 2 weeks and are usually caused by virulent bacteria like S. aureus, while chronic abscesses last over 4-6 weeks and may be caused by tumors or less virulent anaerobes. Lung abscesses are most commonly caused by aspiration of infected materials or inadequately treated pneumonia. Common pathogens include anaerobic bacteria like Prevotella species and aerobic bacteria like S. aureus. Symptoms vary from indolent over weeks to acute, with subacute onset associated with aspiration.
Bronchiectasis
A condition characterized by chronic permanent dilation & destruction of bronchi due to destructive changes in the elastic and muscular layers of bronchial walls.
The common thread in the pathogenesis of bronchiectasis consists of difficulty clearing secretions & recurrent infections with a “vicious circle” of infection and inflammation resulting in airway injury and remodelling.
PLEASE REFER TO REFERENCE TEXTBOOKS FOR CLARITY.
BRONCHIECTASIS BY DR BASHIR AHMED DAR ASSOCIATE PROFESSOR MEDICINE SOPORE KAS...Prof Dr Bashir Ahmed Dar
Bronchiectasis is the irreversible widening of the airways. It develops through one of three mechanisms: damage to the bronchial wall from infections or inflammation, obstruction of the bronchial lumen, or traction from fibrosis in adjacent tissues. Repeated infections, mucus plugging, and bacterial overgrowth lead to a vicious cycle of progressive airway damage and widening in bronchiectasis. Various congenital defects or conditions like cystic fibrosis can also predispose individuals to developing bronchiectasis by impairing mucus clearance from the lungs.
Bronchiectasis is a chronic lung condition characterized by abnormal dilation of the bronchi and bronchioles. It can be caused by airway obstruction, infections, genetic disorders like cystic fibrosis, or immunodeficiencies. Symptoms include chronic cough, excessive sputum production, recurring lung infections, shortness of breath, and finger clubbing. Diagnosis involves chest imaging, sputum analysis, and pulmonary function tests. Treatment focuses on airway clearance techniques, antibiotics for infections, and sometimes surgery to remove diseased portions of the lung.
Empyema is the accumulation of pus in the pleural space caused by a lung infection spreading. It is classified into three stages based on the fluid characteristics. Common causes are bacterial pneumonias like Streptococcus pneumoniae. Symptoms include fever, cough, and chest pain. Chest x-ray or ultrasound can detect fluid buildup. Treatment involves antibiotics, drainage of pus, and occasionally surgery. The goal is to clear the infection, expand the lung, and resolve symptoms. Complications may include persistent fever, abscesses, or fistulae if not properly treated.
Cavitary lung lesions can have various causes including cancer, infection, autoimmune disease, vascular embolism, and trauma. On imaging, characteristics like wall thickness, inner contour, location, and other associated findings provide clues to the underlying etiology. Malignant processes tend to have thicker walls over 15mm while benign lesions usually have thinner walls under 4mm. Infectious cavities often have irregular inner walls and may contain fluid levels. Autoimmune diseases typically cause multiple bilateral nodules. The clinical context is also important for determining the most likely diagnosis.
This document discusses empyema, which is an accumulation of thick, purulent fluid in the pleural space caused by bacterial pneumonia, lung abscess, chest trauma, or surgery. Common organisms include Staphylococcus aureus and Streptococcus pneumoniae. Empyema develops from a parapneumonic effusion through exudative, fibrino-purulent, and organizing stages. Symptoms include fever, chest pain, and dyspnea. Diagnosis involves imaging and culture of pleural fluid. Treatment requires drainage of fluid, antibiotics for 10-14 days intravenously or longer orally, and oxygen. Nursing diagnoses relate to impaired gas exchange, acute pain, and risk for activity intolerance.
Bronchiectasis is the irreversible dilatation of the airways. It can be cylindrical, varicose, or cystic in appearance. Common causes include post-infection, infection by bacteria or mycobacteria, airway obstruction, and immunodeficiencies. Symptoms include persistent cough with sputum, hemoptysis, dyspnea, and wheezing. Diagnosis involves chest x-ray, CT scan, sputum culture, and lung function tests. Treatment goals are to eliminate the cause, improve airway clearance, control infection, and reverse airflow obstruction using antibiotics, chest physiotherapy, bronchodilators, and surgery in some cases.
Lung abscess is a localized, suppurative infection within the lung that forms a cavitating area. It can be caused by inadequately treated pneumonia, aspiration of substances like alcohol or gastric contents, bronchial obstruction by tumors or foreign bodies, pulmonary infarction, septic emboli from infections elsewhere in the body, or subphrenic or hepatic abscesses. Symptoms include swinging fever, cough, purulent sputum, chest pain, hemoptysis, malaise, weight loss, finger clubbing, anemia, and crepitations. Diagnosis involves blood tests, sputum analysis, chest x-rays, and CT scans. Treatment consists of antibiotics selected based on culture sensitivities
Bronchiectasis is a chronic lung condition defined by abnormal dilation of the bronchi. It is commonly caused by previous lung infections but can also be due to other issues like airway obstruction, immune deficiencies, or genetic disorders. Patients present with excessive sputum production, chronic cough, recurrent lung infections, and sometimes blood in the sputum or cough. Diagnosis involves imaging tests like CT scans that show dilated bronchi. Treatment focuses on airway clearance and antibiotics to prevent infections. Surgery may be considered for severe cases or massive bleeding in the lungs.
Lung abscess is a necrotic pulmonary infection that forms cavities containing fluid or debris. It is usually caused by microbial infection following aspiration or pneumonia. Without treatment, lung abscess was often fatal, but antibiotics have greatly improved outcomes. Most lung abscesses are now cured with prolonged antibiotic therapy targeting the usual culprits of anaerobic bacteria and occasionally aerobic pathogens. Imaging helps confirm the diagnosis and monitor response to medical management, with surgery rarely needed for uncomplicated cases.
Common suppurative diseases of lung- Bronchiectasis...!Sharmin Susiwala
Bronchiectasis is a condition characterized by irreversible dilation of part of the bronchial tree due to damage to elastic and muscular components, usually from acute or chronic infection. It requires both an infectious insult and impaired drainage or airway obstruction. Symptoms include daily cough and sputum production. Diagnosis involves chest imaging showing abnormal lung signs and high-resolution CT scanning. Treatment focuses on controlling infections with antibiotics and clearing secretions. Complications can include lung damage and recurrent pneumonia.
This document contains 12 multiple choice questions about lung abscesses. The questions cover topics such as the characteristics of different stages of lung abscess, common symptoms of pneumonia, sites commonly affected by lung abscess, typical blood test results for lung abscess patients, and the preferred treatment for lung abscesses. Radiological features of lung consolidation are also discussed.
Lung abscess or pulmonary abscess is a local suppurative process within the lung.
It is characterized by accumulation of pus accompanied by the destruction of lung tissue.
Content:
Definition
Etiology and pathogenesis
Morphology
Clinical Features
Diagnostic findings
Prevention
Management
1. Lung abscess is a localized necrotic lesion in the lung tissue containing pus, generally caused by aspiration of anaerobic bacteria. It starts as pneumonia, with areas of lung tissue dying off and forming cavities containing pus.
2. Symptoms include fever, cough, sputum production, and chest pain. Diagnosis involves chest x-rays and CT scans to identify fluid-filled cavities.
3. Treatment depends on the size and includes antibiotics, drainage of large abscesses through the chest wall, and surgery if complications occur.
The document provides an overview of respiratory disorders and diseases. It discusses diagnostic tests for respiratory conditions like spirometry and blood gas tests. Common respiratory diseases covered include upper respiratory infections like the common cold, sinusitis, pneumonia, lung cancer, asthma, and chronic obstructive pulmonary disease (COPD). Specific conditions like emphysema and chronic bronchitis are also examined, outlining their pathophysiology, signs and symptoms, diagnosis, and treatment.
Respiratory dis. presentation1 for gen path copy (2)Art Arts
1) Respiratory diseases are mainly caused by inhalation of infectious agents, allergens, irritants, and carcinogens. The lungs are open to the environment and lack regenerative abilities.
2) Chronic obstructive pulmonary diseases (COPD) include chronic bronchitis, emphysema, bronchiectasis, and asthma. Tobacco smoke is a major cause and leads to airway obstruction.
3) Pneumonia can result from impaired pulmonary defenses and host resistance. Bacterial and viral pathogens are common causes and treatment involves antibiotics and supportive care.
The document provides guidelines for collecting and transporting respiratory tract specimen for various infections, including proper labeling and storage. It describes common respiratory tract infections like pneumonia, their causes, symptoms, and treatment options. Pneumonia is classified as lobar, bronchopneumonia, or interstitial based on anatomical location and involvement; and as typical, atypical, community-acquired, or hospital-acquired based on etiology.
1) Emphysema, chronic bronchitis, asthma, and bronchiectasis are obstructive lung diseases. Emphysema and chronic bronchitis are often grouped together as chronic obstructive pulmonary disease (COPD) since most patients have features of both, likely due to cigarette smoking.
2) COPD is a major public health problem and the fifth leading cause of death worldwide. Heavy cigarette smoking and environmental pollutants are significant risk factors.
3) Emphysema is characterized by irreversible destruction of lung tissue and airspace enlargement. It is classified according to anatomical location within the lung lobe. Chronic bronchitis involves inflammation and mucus buildup in the bronchi.
This document discusses the pathophysiology of bronchial asthma and COPD. It covers the definition of asthma as a chronic inflammatory airway condition causing symptoms like wheezing and shortness of breath. Triggers include allergens, pollution, and certain drugs. The pathophysiology involves eosinophilic versus non-eosinophilic inflammation and damage. Clinical manifestations range from persistent cough to acute severe episodes requiring hospitalization. Investigations include spirometry to measure lung function parameters like FEV1, FVC and PEF.
Upper respiratory tract infections like the common cold, sinusitis, and pharyngitis are caused by viruses and bacteria that infect the nose, sinuses, and throat.
The common cold is usually caused by rhinoviruses and presents with nasal congestion and discharge. Sinusitis occurs when the sinuses become infected, often following a viral upper respiratory infection, and can cause facial pain and tenderness. Pharyngitis, or a sore throat, is commonly caused by streptococcus bacteria or viruses like adenovirus. Accurate diagnosis involves examining symptoms, signs, and testing mucus samples. Treatment focuses on relieving symptoms and in some bacterial cases using antibiotics.
The document discusses various respiratory infections including upper and lower respiratory tract infections. It covers topics such as pneumonia, tuberculosis, lung abscess, and bronchiectasis. Pneumonia can be lobar or bronchopneumonia and is classified based on clinical setting, organism, and morphology. Tuberculosis is caused by Mycobacterium and presents as a chronic infection characterized by granulomas and tissue necrosis. Complications of respiratory infections include abscesses, bronchiectasis, and spread to other organs.
BRONCHIECTASIS approach and treatment by Dr.Amira TabidiAmira30013
Pulmonolgy ,it's a common respiratory air way disease with many radiogical features that's vital to learn about it so you can reach the diagnosis easily along with a solid clinical approach
The document discusses pneumonia, including its definition, classification, host defenses in the lung, factors in pathogenesis, pathology, etiology, risk factors, symptoms, signs, diagnosis, and differential diagnosis. It provides extensive details on community-acquired pneumonia, its causes, risk factors, pathogenesis, clinical presentation, diagnostic evaluation and considerations.
This document provides an overview of pneumonia, including:
- Definitions of pathological and clinical pneumonia and classifications based on location and causative factors.
- Host defenses in the lung and factors involved in pathogenesis like routes of infection and microbial/host factors.
- Details on pathology, etiology, symptoms, diagnosis, and treatment of community-acquired pneumonia.
- Risk factors, laboratory tests, imaging approaches and differential diagnosis are discussed. Common causative organisms and diagnostic tests are outlined.
This document provides information on pneumonia and lung abscess from a seminar presentation. It begins with an introduction to pneumonia, defining it as an infection of the lungs. It then discusses the incidence of pneumonia globally and in various countries. Etiology, risk factors, pathophysiology, classification, signs and symptoms, complications, diagnosis, and management of pneumonia are explained. It also provides detail on lung abscess including definition, risk factors, pathophysiology, signs and symptoms, complications, diagnosis, and management. Surgical interventions for complications like empyema are also mentioned.
bronchitis Bronchitis is a condition that develops when the airways in the lu...amerMuhssen
Bronchitis is an infection and inflammation of the bronchial tubes that connect the nose to the lungs. There are two main types: acute bronchitis, which usually follows a cold or flu and lasts a few weeks, and chronic bronchitis, a long-term illness with daily cough and mucus production for at least 3 months per year. Bronchitis is caused by viruses, bacteria, and other irritants and risk factors include smoking, air pollution, and respiratory infections. Symptoms include cough, mucus production, shortness of breath, wheezing, and fatigue. Diagnosis involves medical history, physical exam, chest x-rays, and pulmonary function tests. Treatment focuses on antibiotics, cough medicine, bronchod
The document discusses various respiratory diseases including:
1) Coryza (common cold), sinusitis, rhinitis, pharyngitis, acute laryngotracheobronchitis, influenza, acute bronchitis, pneumonia, COPD, asthma, obstructive sleep apnea, bronchiectasis, lung abscess, cystic fibrosis, and tuberculosis. It provides details on symptoms, investigations, and treatment for each condition.
2) The diseases range from self-limiting viral illnesses like the common cold to chronic inflammatory conditions such as asthma and COPD. Pneumonia can be community-acquired or hospital-acquired and have different causative organisms and treatments.
3)
C:\Documents And Settings\Administrator\桌面\13 UriSumit Prajapati
The document summarizes various respiratory tract infections, including their etiology, clinical manifestations, treatment and prevention. It discusses upper respiratory infections like the common cold, acute infectious laryngitis and acute bronchitis. It also covers lower respiratory infections such as bronchiolitis, pneumonia caused by different pathogens like RSV, adenovirus and Staphylococcus aureus. Diagnosis, classifications, complications and management of pneumonia are described.
Bronchitis is an inflammation of the bronchial tubes caused by viruses, bacteria, or other irritants. There are two main types: acute bronchitis, which usually lasts a few weeks and follows a cold or flu, and chronic bronchitis, a long-term illness with daily cough and mucus production for at least 3 months per year. Symptoms include cough, sputum production, shortness of breath, wheezing, and fatigue. Diagnosis involves medical history, physical exam, chest x-rays, and pulmonary function tests. Treatment focuses on antibiotics, cough medicine, bronchodilators, and anti-inflammatory drugs. Managing risk factors like smoking and avoiding pollutants can help prevent bronchitis.
Here are the definitions and explanation requested:
Croup syndrome is a respiratory illness characterized by inspiratory stridor, cough, and hoarseness caused by inflammation and obstruction of the larynx, trachea, and major bronchi.
Pleurisy is defined as inflammation of the pleura, the thin membrane that lines the chest cavity and covers the lungs. It is also called pleuritis.
The causes of pleurisy include:
- Respiratory infections like pneumonia, tuberculosis, and other bacterial or viral infections that can cause inflammation of the pleura.
- Immune disorders such as systemic lupus erythematosus and rheumatoid arthritis where excess fluid builds up in the pleural space
medical surgical nursing 1
respiratory disorder lower airway
etiology, pathophysiology, clinical manifestations, and nursing management for the patient with pneumonia,chronic bronchitis and emphysema,asthma.
What the structures of the lower airway?
What are the functions of each structure?
This document discusses cough, its mechanism, phases, pathophysiology and approach to patients presenting with cough. It defines cough and outlines its mechanism as a sudden expiratory thrust interrupting breathing. It describes the inspiratory, compressive and expulsive phases of cough. The pathophysiology involves cough receptors in the airways activating afferent nerves that signal the cough center in the brainstem. A detailed history and examination is important to determine the cause and duration of cough. Common causes of acute, subacute and chronic cough are outlined. Investigations including sputum examination, chest imaging and pulmonary function tests may help diagnose the specific condition. Treatment focuses on identifying and treating the underlying cause, with additional options for antitussive agents
This lesson plan provides an overview of acute respiratory infections (ARI). It begins with an introduction to ARIs and their impact. Definitions and classifications of different ARIs are presented, including rhinitis, pharyngitis, tonsillitis, laryngitis, bronchitis, and pneumonia. Causes, clinical manifestations, diagnosis, treatment, nursing management, prevention, and complications are discussed for each type of ARI. The lesson plan aims to guide nursing students in understanding ARIs.
5 Common Mistakes to Avoid During the Job Application Process.pdfAlliance Jobs
The journey toward landing your dream job can be both exhilarating and nerve-wracking. As you navigate through the intricate web of job applications, interviews, and follow-ups, it’s crucial to steer clear of common pitfalls that could hinder your chances. Let’s delve into some of the most frequent mistakes applicants make during the job application process and explore how you can sidestep them. Plus, we’ll highlight how Alliance Job Search can enhance your local job hunt.
How to Prepare for Fortinet FCP_FAC_AD-6.5 Certification?NWEXAM
Begin Your Preparation Here: https://bit.ly/3VfYStG — Access comprehensive details on the FCP_FAC_AD-6.5 exam guide and excel in the Fortinet Certified Professional - Network Security certification. Gather all essential information including tutorials, practice tests, books, study materials, exam questions, and the syllabus. Solidify your knowledge of Fortinet FCP_FAC_AD-6.5 certification. Discover everything about the FCP_FAC_AD-6.5 exam, including the number of questions, passing percentage, and the time allotted to complete the test.
Joyce M Sullivan, Founder & CEO of SocMediaFin, Inc. shares her "Five Questions - The Story of You", "Reflections - What Matters to You?" and "The Three Circle Exercise" to guide those evaluating what their next move may be in their careers.
Learnings from Successful Jobs SearchersBruce Bennett
Are you interested to know what actions help in a job search? This webinar is the summary of several individuals who discussed their job search journey for others to follow. You will learn there are common actions that helped them succeed in their quest for gainful employment.
Job Finding Apps Everything You Need to Know in 2024SnapJob
SnapJob is revolutionizing the way people connect with work opportunities and find talented professionals for their projects. Find your dream job with ease using the best job finding apps. Discover top-rated apps that connect you with employers, provide personalized job recommendations, and streamline the application process. Explore features, ratings, and reviews to find the app that suits your needs and helps you land your next opportunity.
Leadership Ambassador club Adventist modulekakomaeric00
Aims to equip people who aspire to become leaders with good qualities,and with Christian values and morals as per Biblical teachings.The you who aspire to be leaders should first read and understand what the ambassador module for leadership says about leadership and marry that to what the bible says.Christians sh
IT Career Hacks Navigate the Tech Jungle with a RoadmapBase Camp
Feeling overwhelmed by IT options? This presentation unlocks your personalized roadmap! Learn key skills, explore career paths & build your IT dream job strategy. Visit now & navigate the tech world with confidence! Visit https://www.basecamp.com.sg for more details.
Jill Pizzola's Tenure as Senior Talent Acquisition Partner at THOMSON REUTERS...dsnow9802
Jill Pizzola's tenure as Senior Talent Acquisition Partner at THOMSON REUTERS in Marlton, New Jersey, from 2018 to 2023, was marked by innovation and excellence.
Resumes, Cover Letters, and Applying OnlineBruce Bennett
This webinar showcases resume styles and the elements that go into building your resume. Every job application requires unique skills, and this session will show you how to improve your resume to match the jobs to which you are applying. Additionally, we will discuss cover letters and learn about ideas to include. Every job application requires unique skills so learn ways to give you the best chance of success when applying for a new position. Learn how to take advantage of all the features when uploading a job application to a company’s applicant tracking system.
2. Plan of the lecture
1. Definition bronchitis
2. Etiology
3. Bronchitis pathogenesis
4. Clinic groups of bronchitis in
children
5. Bronchitis treatment
3. Bronchitis is an inflammatory
disease of bronchi mucous
membrane with clinical
presentation of cough, sputum
production, dyspnea in case of
small bronchi affection
4. Problem is actual due to
- Frequent morbidity
-Frequent complication of pneumonia
-Tendency for recurrent and
complicated course
-Predisposing for atopic reactions with
further formation of obstructive forms,
bronchial asthma
-High financial demands for treatment
5. Predisposing factors
- Nose congestion ( due to narrowing of nose
ways, anatomic disorders of nasal septum
Focuses of infection in upper respiratory
tract ( rhinitis, sinusitis, tonsillitis)
Immune response abnormality ( immaturity
of immune system in infants and toddlers
Co-morbidities (allergic rhinitis, sinusitis,
laryngitis)
Passive and early active smoking,
toxicomania
Carriage of provisional microflora in
respiratory tract
Unfavourable weather ( high humidity,,
deviations in surrounding temperature etc)
6. Etiology
There are 3 groups
Infectious bronchitis ( viruses, bacteria, atypical
microorganisms, fungus, protozoal)
Noninfectious, due to influence of various
allergens, toxic substances, physical factors on
mucous membrane
Mixed etiology influence of infectious factors as
well noninfectious
7. Infectious bronchitis
Viral –typical for predominant acute
and recurrent forms of disease (65-
90%). More frequently are influenza,
parainfluenza, rhino-syncitial, adeno-,
rhino-, corona-, rota- entero- viruses
8. Bacterial bronchitis are usually complications
of viral process in respiratory tract
The main bacterial causative factors of bronchitis in children
( data of Geraschenko T.I., 2002)
Streptococcus pneumoniae +++
Streptococcus viridans +
Klebsiella pneumoniae ++
Haemophilus influenzae +++
Moraxella catarrhalis +++
Staphilococcus aureus +
Mycoplasma pneumoniae ++
Chlamidia pneumoniae +
The most significant are Candida, Aspergillus among fungus
infection
9. Bronchitis pathogenesis
Etiologic factor
Phagocyte migration, proinflammatory
mediators releasing (cytokines,
enzymes), their storage in mucous
membrane
Respiratory tract mucous membrane
direct impairment
Vessel reaction
Vasodilation
Increased permeability of
vessel wall
Exudation
Mucous membrane edema
Bronchial hypersecretion
due to irritation and dilation of goblet cells
11. 1.Pathologic
microorganisms
damage local tissues
and stimulate releasing
of prostglandins and
hystamine. They cause
edema, pain and attract
neutrophils and
another effector cells
Bronchi mucous
membrane
Простагландины
Микроорганизмы
Нейтрофилы
12. 2. Microorganisms
release toxins,
stimulate neutrophils’
permeability from
circulation (neutrophils
by diapedesis penetrate
through pores in
vessels’ endothelium
and direct towards
affected site)
Blood vessesl
Neutrophil
13. 3. Antibodies are
special proteins
that can attach to
microorganisms.
New neutrophils
has receptors to
recognize
antibodies and
pathogens and
they also attach
to complexes Antibody
Receptor
14. 4. Neutrophils
create
pseudopodias and
absorb pathogens
by this structures.
Digestion of
microbes is
performed by
enzymes in
phagolyzosomes (
i.e. phagocytosis
is performed)
Lyzosome
Neutrophil captures
microorganism
15. 5. Microorganisms are
destroyed. Remnants
of pathogens can be
excreted on cell
membrane
Microorganism
eradication
Destroyed
microorganism
16. Changes of bronchi in bronchitis
These are pictures of healthy normal bronchi (1) and bronchus in bronchitis
(2), bronchial lumen is narrow
1 2
17. Bronchitis diagnostics
All clinical symptoms can be divided for
Main constant ( cough, production of
sputum)
Additional, transient ( rales, obstructive
syndrome, dyspnea)
18. Cough is a “guard dog of bronchi”
Complex reflectory mechanism
that protects respiratory tract and
remove foreign bodies or
pathologic material, excess of
sputum from bronchi and maintain
bronchial patency
19. Any inflammatory process in respiratory tract
impairs mucociliar clearance due to
Partial loosing of cilia epithelium in
bronchi
Impairment of secret moving
Secret layer increasing
Raising secret viscosity
Secret accumulation in various parts of
respiratory tract
20. Clinic groups of bronchitis in children
Pathogenesis
Primary
Secondary
Etiology
Infectious
Viruses
Bacterial
Mixed ( viral, bacterial)
Fungus
Noninfectious
Allergic factors
Chemical factors
Physical factors
Smoke
Mixed
due to infectious and noninfectious factors
21. Clinic groups of bronchitis in children
Course
Acute (not more than 2-3 weeks)
Lingering ( more than 3 weeks to 1 mo)
Recurrent ( repeat more than 3 times per year, phase
of exacerbation and remission)
Clinic type
Simple ( nonobstructive)
Obstructive
Affected level
Tracheitis
Tracheobronchitis
Bronchitis
Bronchiolitis
22. Tracheitis(J 04.1)
Trachea mucous membrane
inflammation as a result of acute
respiratory disease of viral etiology
Disease can be accompanied by
inflammation of larynx
(Laryngotracheitis, J 04.2) or in
bronchi ( Tracheobronchitis, J 20)
23. Acute simple bronchitis ( J 20- J 20.9)
Acute bronchial mucous membrane inflammation
predominantly is caused by viral infection
Symptoms of viral intoxication: common condition
impairment, chills, decreased appetitie, behavioral
changes of child, flaccidity, weakness or excitability,
impairment of sleeping, fever, head ache, transient
muscle pains, catarrhal events in nasopharynx
Symptoms of bronchitis: cough, sputum production,
formation of rales, dyspnea
Physical examining: percussion and palpation
without changes
Auscultative changes: rough bronchial sound,
prolonged expiration, bilateral rales in various parts
of lungs changes after cough
Hemogram changes: elevated ESR while normal or
decreased leucocyte count
Chest X-ray: enhancing of bronchial linearity, root
shadow is wide, not clear
24. Obstructive bronchitis (J 20)
Special clinic type of disease with bronchial obstructive
syndrome due to inflammatory decreasing of bronchial
aperture
Diagnostic criteria
Common condition impairment, rhinitis symptoms,
nasopharyngitis, catarrhal symptoms
Body temperature normal sometimes subfebrile, rarely
hyperthermia
Manifested respiratory failure
Signs of bronchial patency abnormality
During percussion: tympanic sound
Auscultation – rough bronchial sound, prolonged
expiratory sound, moist bubbling rales, during expiration
dry whistling (wheezing) rales
Manifested tachycardia
X-ray picture - intensification of vascular picture,
increased clearance of lungs due to emphysema,
amplification of bronchial picture
25. Factors of bronchial asthma
development
Recurrent obstruction ( three and more episodes of
obstruction)
Atopy inheritance
Obstruction is initiated by contact with allergens of
noninfectious nature
Proved dust, epidermal and other types of sensibilization
Co-morbidities: another allergic diseases like atopic
dermatitis, allergic rhinitis, conjunctivitis
IgE level I blood is more than 100IU/l
•Bronchoscopic picture in
obstructive bronchitis; in
aperture of left main
bronchus solid sputum clot
is visualised
26. Bronchiolitis ( J-21 – J 21.9)
Acute generalized obstructive disease of distal
respiratory tract – terminal bronchi
Disease develops only in infants
Clinical peculiarities of bronchiolitis
Progressive dyspnea
Nonproductive cough
Manifested signs of severe bronchoobstructive
syndrome
Signs of respiratory failure
Another organs and systems reactions
(cardiovascular syndrome, hypoxic changes of CNS)
Percussion tympanic resonance
Auscultation bilateral manifested respiratory sound
attenuation, expiratory sound isn’t audible. In basal
part of lung crepitation or bubbling sound on the
ground of attenuated breathing sound, special
“inspiratory” peep is audible
27. Chronic bronchitis (J 40-J 42)
Disease is characterized by episodic or constant cough
and sputum production for 2 or more years,
summary duration of productive cough is more than
3 mo per year
Diagnostic criteria of chronic bronchitis in children
Prolonged pulmonologic anamnesis
Stable clinic signs, impaired tolerance of physical
loadings, changed shape or deformities of chest,
thickening of distal phalangs and nails
Stable (local or spread) physical changes in lungs
Radiologic signs “Solidified” X-ray picture with
emphysema signs, pneumofibrosis, manifested
deformity of lung picture
Deformity of bronchi
Stable, sometimes progressive respiratory function
impairment
28. Bronchitis treatment
Indications for hospitalization
Severe course of bacterial bronchitis, manifested signs of
intoxication
Complicated bronchitis – with manifested mucus retention,
impaired bronchial patency, atelectasis formation etc.
Bronchiolitis ( in children of less than 1 y.o. because of
threatening of emergency conditions)
Severe types of Obstructive bronchitis (OB) – especially
resistant for treatment in ambulatory conditions
Lingering and recurrent bronchitis ( for diagnostic and
treatment)
Chronic forms of disease ( for treatment and full
examining)
Bronchitis on the ground of another somatic severe
diseases ( CNS, anomalies and malformations of organs
chronic disorders
Social reasons
29. Bronchitis treatment
Regimen: special regimen isn’t
necessary but more proper home
regimen for all acute period
Diet: must be rational rich in vitamins
Medical treatment:
Etiotropic
Pathogenic
30. Etiotropic treatment in bronchitis
1.Antiviral treatment
Indications for antiviral medication:
In moderate and severe courses of viral infection
accompanied by bronchitis
In children with respiratory support
For bronchitis prevention in group of frequently
and severe ill children
For prophylaxis and treatment of premature
children
In complex treatment of recurrent bronchitis
For prophylaxis of chronic bronchitis
exacerbations
33. Etiotropic bronchitis treatment
2. Antibacterial treatment
Indications for prescribing antibacterial treatment
Fever (T> 38C for more than 3 days), especially in
infants
Intoxication signs
Purulent sputum production together with intoxication
Presence of chronic focus of infection together with
bronchitis (purulent otitis, rhinitis, sinusitis,
lymphadenitis etc)
Lingering ( more than 2 weeks) or recurrent course of
disease
Premature child or infants of first 6 mo old with law
indexes of health
Unfavourable premorbid phone of disease
Chronic bronchitis exacerbations with clinic indexes of
bacterial infections
Hospital bronchitis
34. Etiotropic bronchitis treatment
2. Antibacterial treatment
Antibiotic treatment approach
Choice of start antibiotic
Choice of proper medication delivery (oral, IV
way)
Choice of effective antibiotic is performed
empirically taking into account more
probable causative factor according to site of
infection (community acquired, hospital),
patient age, premorbid phone, severity of
bacterial process
35. Etiotropic bronchitis treatment
2. Antibacterial treatment
Medications of choice
Aminopenicillines with β –lactamase inhibitors
(amoxiclav, augmentin)
Cephalosporines I-III generations ( cephazoline,
cefalexin, Cefaclor, cefuroxim, cefotaxim,
ceftriaxone)
Macrolides ( azitromycine, clarythromycine)
alternative medications ( in case of β-lactams
antibiotic intolerance)
In case of local inflammative process (
laryngotracheitis, tracheitis, tracheobronchitis) –
topical antibiotic (bioparox-fuzenzhin)
36. Pathogenic bronchitis treatment
Principles of treatment
Respiratory tract mucous membrane
inflammation suppression
Normalization of secretory aparatus
and mucociliary transport functioning
Control of cough reflex
Restoration of bronchial patency
(bronchial obstruction elimination)
37. Pathogenic bronchitis treatment
Antiinflammatory treatment
Erespal ( Fenspirid) – perform multiple action on inflammation,
action is similar to corticosteroids but without side effects
typical for steroid therapy
Effects of Erespal
Influence of vessel and cell components of inflammation that
decrease permeability of vessels exudation and edema
Partial blockage of α-adrenoreceptors that decrease
hypersecretion of sputum
Influence of bronchial patency due to spasmolytic action on
smooth muscles and improvement of mucociliar clearance
Antagonist activity o H-1 hystamine receptors, decreasing
synthesis and inhibition action of hystamine
Decreasing of leucocyte infiltration
Nondirect influence for cough intensity
38. Pathogenic bronchitis treatment
Secretory function and mucociliary
transport normalizing
All medications that influence to these processes
can be divided into 6 main groups
Mucokinetics or expectorant
Respiratory tract secret rehydrant medication
Mucolytics or medications that directly influence on
secret rheologic properties
Mucoregulators
Medications that stimulate lung surfactant production
Antipertussis medication
39. Pathogenic bronchitis treatment
Secretory function and mucociliary
transport normalizing
Mucokinetics – expectorant (secret-
motor) medications
Mucaltin
Bronchicum
Tussin
40. Pathogenic bronchitis treatment
Secretory function and mucociliary
transport normalizing
Resorbtive medications- respiratory tract
secret rehydrants
1-3% water solutions of sodium and potassium
iodides ( 1 teaspoon -1 big spoon after feeding with
big quantity of water)
0,5-2,5% ammonium chloride water solution
(1teaspoon-1big spoon 5-6 times/per day after
feeding with big quantity of warm water)
1-2% sodium hydrocarbonatis water solution per os
or for inhalations
41. Pathogenic bronchitis treatment
Secretory function and mucociliary
transport normalizing
Secretolytics – medication that regulate secret
rheological properties
Nondirect activity
Change biochemical mucus
composition or production
S-carboxymethylcystein,
sorbeol, bromhexinum
Change adhesive properties of gel
layer
ambroxol, sodium bicarbonatis
Influence on zole layer and
rehydration
water, sodium and potassium
salts solutions
Volatile substances and balsams terpens
42. Pathogenic bronchitis treatment
Secretory function and mucociliary
transport normalizing
Secretolytics
Direct action
destroy polymers
of mucus
Tiols Cystein, acetylcystein, pyopronin,
mesna
Enzymes trypsin, β-chemotrypsin
Other Ascorbic acid, hypertonic NaCl
solution, nonorganic iodides
43. Pathogenic bronchitis treatment
Secretory function and mucociliary
transport normalizing
Medications that regulate secret production and its
rheologic properties (carbocystein derivatives)
Fluditec (carbocystein)
Fluifort(Carbocystein salt of lysine)
Mucodin (D-carbocystein)
Mucopront (Carbocistein)
44. Pathogenic bronchitis treatment
Secretory function and mucociliary
transport normalizing
Mucoactive medications ( that improve rheologic
properties and influence on surfactant
synthesis)
Ambrohexal (ambroxol)
Ambrosan (ambroxol)
Lasolvan ( ambroxol hydrochloride)
Ambene
Cholycsol
Bisolvon
45. Pathogenic bronchitis treatment
Secretory function and mucociliary
transport normalizing
Mucoactive medications pharmacological properties
Mucoregulation
Mucolytic
Secretomotor effect
Elimination, connected with increased mucus fluidity and its
expectoration
Metabolic – activation of alveolar surfactant
Antiinflammative and immunomodulative action
Lung protection from oxydative stress and decreasing of bronchi
hyperreactivity
Partial suppression of cough reflex
46. Pathogenic bronchitis treatment
Secretory function and mucociliary
transport normalizing
Antipertussis medication – predominant effect
is suppressing of cough reflex
Peripheral action Central action
lybexin,
tussuprex,
levopront
Narcotic
medication
codein, dionin
Nonnarcotic
medication –
synecod,
glauvent,
tusuprex,
sedotussin
48. Questions
Acute bronchitis in childhood.
Classification bronchitis.
What causes acute bronchitis?
Clinical forms bronchitis.
Acute obstructive bronchitis and recurrent bronchitis
Bronchiolitis.
Clinical manifestations. Diagnosis.
Can medicine treat acute bronchitis?
Antiviral treatment.
Will antibiotics help acute bronchitis?
Rational antibiotic and hormone treatment.
What about oxygen therapy?
Immunotherapy.
Physiotherapy.
Therapeutic bronchoscopy.
What can I do to help my breathing and reduce my coughing?